Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Coagulation and fibronolysis

Citations 1-10 of 11 total displayed.

Most recent content (1 Jun 2008):

Original Articles
Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System
Muhannad Masoud, Galit Sarig, Benjamin Brenner, and Giris Jacob
Hypertension 51: 1545 -1551; published online before print as doi:10.1161/HYPERTENSIONAHA.108.112003 [Abstract] [Full text]  

Past content (since Jun 1999):

Scientific Contributions
Orthostatic Hypercoagulability. A Novel Physiological Mechanism to Activate the Coagulation System
Muhannad Masoud, Galit Sarig, Benjamin Brenner, and Giris Jacob
Hypertension published April 14, 2008, doi:10.1161/HYPERTENSIONAHA.108.112003 [Abstract]  

Brief Reviews
The Prothrombotic Paradox of Hypertension: Role of the Renin-Angiotensin and Kallikrein-Kinin Systems
Arne W.J.H. Dielis, Machiel Smid, Henri M.H. Spronk, Karly Hamulyak, Abraham A. Kroon, Hugo ten Cate, and Peter W. de Leeuw
Hypertension 46: 1236 -1242; published online before print as doi:10.1161/01.HYP.0000193538.20705.23 [Abstract] [Full text]  

Brief Reviews
The Prothrombotic Paradox of Hypertension. Role of the Renin-Angiotensin and Kallikrein-Kinin Systems
Arne W.J.H. Dielis, Machiel Smid, Henri M.H. Spronk, Karly Hamulyak, Abraham A. Kroon, Hugo ten Cate, and Peter W. de Leeuw
Hypertension published November 14, 2005, doi:10.1161/01.HYP.0000193538.20705.23 [Abstract]  

Editorial Commentaries
Morning Surge and Variability in Blood Pressure: A New Therapeutic Target?
Kazuomi Kario
Hypertension 45: 485 -486; published online before print as doi:10.1161/01.HYP.0000158313.57142.3f [Full text]  

Editorial Commentary
Morning Surge and Variability in Blood Pressure. A New Therapeutic Target?
Kazuomi Kario
Hypertension published February 21, 2005, doi:10.1161/01.HYP.0000158313.57142.3f [Abstract]  

Scientific Contributions
Antithrombotic Effect of Captopril and Losartan Is Mediated by Angiotensin-(1-7)
Iwona Kucharewicz, Robert Pawlak, Tomasz Matys, Dariusz Pawlak, and Wlodzimierz Buczko
Hypertension 40: 774 -779; published online before print as doi:10.1161/01.HYP.0000035396.27909.40 [Abstract] [Full text]  

Scientific Contributions
Antithrombotic Effect of Captopril and Losartan Is Mediated by Angiotensin-(1-7)
Iwona Kucharewicz, Robert Pawlak, Tomasz Matys, Dariusz Pawlak, and Wlodzimierz Buczko
Hypertension published September 23, 2002, doi:10.1161/01.HYP.0000035396.27909.40 [Abstract]  

Scientific Contributions
Angiotensin II and Its Metabolites Stimulate PAI-1 Protein Release From Human Adipocytes in Primary Culture
Thomas Skurk, Yu-Mi Lee, and Hans Hauner
Hypertension 2001; 37: 1336-1340 [Abstract] [Full text]  

Scientific Contributions
Effect of Antioxidant Therapy on Blood Pressure and NO Synthase Expression in Hypertensive Rats
Nosratola D. Vaziri, Zhenmin Ni, Fariba Oveisi, and Debra L. Trnavsky-Hobbs
Hypertension 2000; 36: 957-964 [Abstract] [Full text]  

[Next page]
Pages: 1 2

* Subspecialty Collections Home

* Show  Coagulation and fibronolysis
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors